NCT06625593 2026-04-16
A First-in-Human (FIH) Study of BG-C137, an Anti-Fibroblast Growth Factor Receptor 2b (FGFR2b) Antibody Drug Conjugate, in Participants With Advanced Solid Tumors
BeOne Medicines
Phase 1 Recruiting
BeOne Medicines
Day One Biopharmaceuticals, Inc.
ARCAGY/ GINECO GROUP
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Anhui Provincial Hospital
Tianjin Medical University Cancer Institute and Hospital
Xi'an Jiaotong University
The Affiliated Hospital of Qingdao University
The Second Hospital of Shandong University
Shandong University
Shaare Zedek Medical Center
Gencurix, Inc.